Drawing upon decades of experience, RAND provides research services, systematic analysis, and innovative thinking to a global clientele that includes government agencies, foundations, and private-sector firms.
The Pardee RAND Graduate School (PardeeRAND.edu) is home to the only Ph.D. and M.Phil. programs offered at an independent public policy research organization—the RAND Corporation.
Assistant Policy Researcher, RAND, and Ph.D. Student, Pardee RAND Graduate School
Ph.D. Student, Pardee RAND Graduate School, and Assistant Policy Researcher, RAND
Men denied enrollment into the IMPACT program exhibited worse symptom distress and self-efficacy compared to enrolled men at initial assessment.
Jan 1, 2007
The authors ascertained the health care costs of androgen deprivation therapy and related skeletal events.
In the current study, treatment for localized prostate cancer was found to differentially affect HRQOL outcomes.
Among the challenges that face physicians who care for men with prostate cancer is evaluating the patient's potential for benefiting from treatment.
The authors identified sociodemographic characteristics that predict poor disease understanding in low income, uninsured men with prostate cancer.
The authors assessed adherence with the CAP RP practice protocol in a national sample of men who underwent RP for early-stage prostate cancer.
Variations in patterns of care and treatment outcomes suggest differences in the quality of care for men treated for localized prostate cancer.
The use of androgen deprivation therapy (ADT) in the treatment of men with prostate cancer has risen sharply.
The knowledge scale developed in this study holds promise for measuring the effects of professional education on prostate cancer screening.
Jan 1, 2006
Comorbidity is one of many factors that may affect health-related quality of life (HRQOL) in men with prostate cancer.
Information and understanding are needed so that men with prostate cancer can effectively manage and cope with their disease.
Further research is needed to establish the effects of this strategy on symptoms and survival, as well as patient satisfaction and true costs.
Postprostatectomy salvage radiotherapy may improve PSA progression-free survival, but little is known about its effect on quality of life.
Spirituality is interdependent with the biological, psychological, and interpersonal aspects of life.
A 66-year-old man with hypertension, hyperlipidemia, and benign prostatic hyperplasia presented for evaluation of an elevated PSA level of 6.2 ng/ml.
Patterns of care after primary prostate cancer therapy continue to vary regionally.
Improvement in the quality of care for men with prostate cancer may be achieved not by treating more patients but by treating them more discerningly.
Cause-specific mortality rates among men with prostate cancer that suggest early diagnosis and treatment for localized tumors may improve survival.
Within a framework of quality assessment, primary treatment choice constitutes an indicator of quality of care.
Jan 1, 2005
To validate an Italian version of the University of California-Los Angeles Prostate Cancer Index (UCLA-PCI).